Xiaoling Li

4.7k total citations
116 papers, 3.6k citations indexed

About

Xiaoling Li is a scholar working on Oncology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Xiaoling Li has authored 116 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 37 papers in Molecular Biology and 18 papers in Cellular and Molecular Neuroscience. Recurrent topics in Xiaoling Li's work include Viral-associated cancers and disorders (10 papers), Cancer-related Molecular Pathways (8 papers) and Neuroinflammation and Neurodegeneration Mechanisms (7 papers). Xiaoling Li is often cited by papers focused on Viral-associated cancers and disorders (10 papers), Cancer-related Molecular Pathways (8 papers) and Neuroinflammation and Neurodegeneration Mechanisms (7 papers). Xiaoling Li collaborates with scholars based in China, United States and Germany. Xiaoling Li's co-authors include Guiyuan Li, David J. Chen, Honghai Ouyang, Gloria C. Li, Xiayu Li, Zhiyuan Zeng, Kathleen K. Blizzard, A. Courtney DeVries, Patricia D. Hurn and Louise D. McCullough and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Xiaoling Li

107 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoling Li China 34 1.7k 733 582 416 362 116 3.6k
Huang Huang China 29 1.5k 0.9× 343 0.5× 376 0.6× 430 1.0× 362 1.0× 102 3.4k
Farshid Noorbakhsh Iran 36 1.4k 0.8× 440 0.6× 759 1.3× 784 1.9× 364 1.0× 127 3.9k
Osamu Inanami Japan 34 1.9k 1.1× 351 0.5× 408 0.7× 602 1.4× 373 1.0× 182 4.2k
Danyang Chen China 31 1.5k 0.9× 461 0.6× 362 0.6× 255 0.6× 165 0.5× 167 3.7k
Ricardo G. Correa United States 30 1.5k 0.9× 451 0.6× 523 0.9× 899 2.2× 293 0.8× 54 3.2k
Dexi Chen China 39 3.0k 1.8× 802 1.1× 1.0k 1.8× 649 1.6× 317 0.9× 193 5.7k
Xiaojuan Li China 41 2.7k 1.5× 812 1.1× 726 1.2× 828 2.0× 168 0.5× 247 5.7k
Min Luo China 36 2.3k 1.3× 706 1.0× 663 1.1× 665 1.6× 207 0.6× 206 4.9k
Kenichi Tanaka Japan 42 2.6k 1.5× 573 0.8× 409 0.7× 649 1.6× 360 1.0× 243 6.1k
Megan R. Lerner United States 32 2.0k 1.2× 694 0.9× 1.2k 2.0× 388 0.9× 248 0.7× 124 4.0k

Countries citing papers authored by Xiaoling Li

Since Specialization
Citations

This map shows the geographic impact of Xiaoling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Li more than expected).

Fields of papers citing papers by Xiaoling Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Li. The network helps show where Xiaoling Li may publish in the future.

Co-authorship network of co-authors of Xiaoling Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoling Li. A scholar is included among the top collaborators of Xiaoling Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoling Li. Xiaoling Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yilong, Ruiqi Li, Mu Zhang, et al.. (2025). Extracellular matrix-mimicking cryogels in tissue engineering and cancer therapy: from structural design to translational applications abstract. Journal of Materials Chemistry B. 13(44). 14166–14193. 1 indexed citations
2.
Cheng, Yao, Liqiang Wu, Suying Lü, et al.. (2025). 336P: Durvalumab (D) as consolidation therapy for limited-stage small-cell lung cancer (LS-SCLC): ADRIATIC China subgroup analysis. Journal of Thoracic Oncology. 20(3). S203–S204.
3.
Qin, Ke, Xiaohong Chen, Xiaoling Li, et al.. (2025). Eno1 in sepsis-induced coagulopathy: a pleiotropic mechanism hypothesis involving immunomodulation and endothelial dysfunction. Thrombosis Journal. 23(1). 62–62. 1 indexed citations
4.
Zhang, Chunguo, Caixia Xu, Haohao Yan, et al.. (2024). Correlations between alterations in global brain functional connectivity in patients with major depressive disorder and their genetic characteristics. The World Journal of Biological Psychiatry. 25(9). 560–570. 1 indexed citations
5.
Li, Xiaxi, Xiaoling Li, Hong Xiao, et al.. (2024). Meta-analysis of gut microbiota alterations in patients with irritable bowel syndrome. Frontiers in Microbiology. 15. 1492349–1492349. 3 indexed citations
6.
7.
Hui, Zhenzhen, Jiali Zhang, Xiaoling Li, et al.. (2022). Single-cell profiling of immune cells after neoadjuvant pembrolizumab and chemotherapy in IIIA non-small cell lung cancer (NSCLC). Cell Death and Disease. 13(7). 607–607. 39 indexed citations
8.
Li, Xiaoling, Xiaojie Shi, Yang Yu, et al.. (2022). Metabolic indexes of obesity in patients with common mental disorders in stable stage. BMC Psychiatry. 22(1). 91–91. 9 indexed citations
9.
Liu, Ying, Ying Cheng, Qiming Wang, et al.. (2021). Effectiveness of anlotinib in patients with small‐cell lung cancer and pleural effusion: Subgroup analysis from a randomized, multicenter, phase II study. Thoracic Cancer. 12(22). 3039–3045. 8 indexed citations
10.
Li, Xiaoling, et al.. (2020). Effects of exogenous calcium on physiological characteristics of Scutellaria baicalensis seedlings under salt stress.. Guangdong nongye kexue. 32(1). 13–18. 1 indexed citations
11.
Tu, Yingfeng, Xiaoling Li, Xuefei Zhu, et al.. (2020). Determining the Fate of Neurons in SCA3: ATX3, a Rising Decision Maker in Response to DNA Stresses and Beyond. Frontiers in Cell and Developmental Biology. 8. 619911–619911. 5 indexed citations
12.
Li, Xiaoling, et al.. (2019). Effects of initiators on seed germination and seedling drought tolerance of Scutellaria baicalensis Georigi.. He'nan nongye kexue. 48(8). 61–67.
13.
Qin, Jie, et al.. (2018). Relationship between social support and social function in patients with breast cancer after mastectomy. Zhonghua xiandai huli zazhi. 24(8). 923–926. 1 indexed citations
14.
Chen, Shengnan, Pan Zheng, Wei Wang, et al.. (2017). Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN‐induced hepatocellular carcinoma. Journal of Cellular Physiology. 233(6). 5002–5013. 27 indexed citations
15.
Zhao, Jianfu, Delong Zeng, Yuedan Liu, et al.. (2017). Selenadiazole derivatives antagonize hyperglycemia-induced drug resistance in breast cancer cells by activation of AMPK pathways. Metallomics. 9(5). 535–545. 9 indexed citations
16.
Guo, Gang, et al.. (2016). EGF and curcumin co-encapsulated nanoparticle/hydrogel system as potent skin regeneration agent. International Journal of Nanomedicine. Volume 11. 3993–4009. 93 indexed citations
17.
Hammer, Adam M., Omair Khan, Niya L. Morris, et al.. (2015). The Effects of Alcohol Intoxication and Burn Injury on the Expression of Claudins and Mucins in the Small and Large Intestines. Shock. 45(1). 73–81. 21 indexed citations
18.
Yang, Yixin, Qianjin Liao, Wei Fang, et al.. (2013). Correction: LPLUNC1 Inhibits Nasopharyngeal Carcinoma Cell Growth via Down-Regulation of the MAP Kinase and Cyclin D1/E2F Pathways. PLoS ONE. 8(8). 1 indexed citations
19.
Zheng, Ying, Wenling Zhang, Qiurong Ye, et al.. (2012). Inhibition of Epstein-Barr Virus Infection by Lactoferrin. Journal of Innate Immunity. 4(4). 387–398. 33 indexed citations
20.
Li, Xiaoling. (2004). Clinical application of flurbiprofen axetil injection. Chinese New Drugs Journal. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026